At Roivant, we are passionate about discovering and developing new drugs to impact patients’ lives. Since its inception in 2014, Roivant has launched over 20 portfolio companies (Vants), overseen 5 successful IPOs, established a $3B partnership with a global pharma, built a pipeline of over 40 assets across various modalities and therapeutic areas, and delivered 8 successful phase 3 readouts. Roivant is currently building new capabilities in drug discovery and expanding its existing development engine to become the world’s leading tech-enabled pharmaceutical company.
Position Summary: This position is a unique role among biotechnology companies as it more closely resembles a buy-side investor role, rather than a conventional business development position in a biopharmaceutical company. In this role, you will be responsible for building the scientific/clinical rationale and investment case for novel drug development ideas and drug acquisition targets. Because it involves the sourcing, assessment, and in-licensing of new assets and new company creation, this position is essential to achieving Roivant’s growth targets and company mission.
Responsibilities:
- Understand the broad biotech/pharmaceutical market landscape and clinical development process for marketing approval
- Review, aggregate, analyze and monitor pharmaceutical development databases and market research reports
- Help develop and grow a robust pipeline of targets by searching publicly available databases and online resources for novel drug development ideas
- Create and maintain an internal database of potential acquisition candidates
- Conduct in-depth scientific, clinical and market research and financial modeling to support recommendations
- Help inform the investment thesis through rigorous modeling of potential commercial launch trajectories and revenue projections
- Construct persuasive investment theses in the form of PowerPoint presentations and supporting Excel models
- Communicate theses directly to senior management advocating for specific drug development projects
- Partner with senior members of the Investment group to assist with all elements of transactions on new investments through closing, including due diligence, valuation, deal structuring, and negotiations
Skills & Qualifications:
- Familiarity with the major scientific and medical aspects of drug development
- Strong scientific and analytical skills and attention to detail
- Experience writing research reports and delivering presentations that integrate multiple data sources
- Proficiency with MS Office suite, including functions and pivot tables (Word, Excel, and PowerPoint)
- Experience using multiple pharmaceutical competitive intelligence databases
- Excellent written and verbal communication skills
- Ability to work cross-functionally within the organization (marketing, R&D, finance, etc.)
Experience & Education Requirements:
- Two to three years of buy-side healthcare investing experience, primarily focused on therapeutics (or the equivalent 5-7 years of skill-building in a related discipline (e.g., VC, sell side research)
- Bachelor’s degree required (preferably in science); advanced degree (e.g., PhD, MD, MBA, MSc) preferred
Compensation:
- Competitive compensation and benefits package, including initial equity grant
- Significant bonus compensation upon contribution of a drug development idea(s) that add value to the organization
- Equity grants are offered annually for top performers
If interested, please apply here.
